Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pigs ‘could be a better model for human influenza’
The results suggest that targeting the lower respiratory tract with aerosol vaccination could be more effective in preventing severe disease.

’Striking difference’ to the same vaccine in pigs and ferrets 

A new study has raised questions about whether ferrets are a good model for studying human influenza.

Ferrets are considered to be a gold standard animal model for influenza research, but scientists now say that S-FLU - a universal flu vaccine candidate - evokes different immune responses in pigs and ferrets.

Findings published in the Journal of Immunology suggest that pigs may offer a more faithful representation of influenza disease in humans.

S-FLU is a weakened strain of flu virus, designed to trigger a response from T cells that are able to react to multiple strains of flu.

Researchers found a ‘striking difference’ in the way that pigs and ferrets responded to the same vaccine. When administered to pigs, the vaccine activated a newly-identified type of T cell, against a flu virus of a different strain. Disease severity was reduced, but the amount of virus stayed the same.

When it was administered to ferrets, however, the viral replication was reduced, as was the amount of virus transmitted to other animals. Scientists said pigs provide a model that is closer in size and has a very similar respiratory system to humans. Pigs are also naturally infected with influenza viruses.

The team’s discovery of a new type of T cell - tissue-resident memory T-cells - also sheds light on how influenza is fought in the lung.

The results also suggest that targeting the lower respiratory tract with aerosol vaccination could be more effective in preventing severe disease in pigs. This finding offers promising evidence that the same could be true in humans.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.